COMPARISON OF ANTI-HIV AND ANTI-HCV THERAPY COSTS IN THE CZECH REPUBLIC

被引：0
|
作者：
Stefancikova, I [1 ]
Mazel, T. [1 ]
Haluska, M. [1 ]
Chytilova, P. [1 ]
Strnadova, M. [1 ]
Mahovska, R. [1 ]
Vocelka, M. [1 ]
机构：
[1] State Inst Drug Control, Prague 10, Czech Republic
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN60
引用
收藏
页码：S649 / S649
页数：1
相关论文
共 50 条
  • [41] The Evaluation of HBsAg, Anti-HCV and Anti-HIV Results in Blood Donors Applying to the Transfusion Center of Batman State Regional Hospital
    Turk-Dagi, Hatice
    KLIMIK JOURNAL, 2011, 24 (03) : 173 - 175
  • [42] Epitope mapping of anti-HIV and anti-HCV monoclonal antibodies and characterization of epitope mimics using a filamentous phage peptide library
    Grihalde, ND
    Chen, YCJ
    Golden, A
    Gubbins, E
    Mandecki, W
    GENE, 1995, 166 (02) : 187 - 195
  • [43] Anti-HCV seroreversion in HIV-negative haemophiliacs
    Aguilar, C
    Lucia, JF
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 (02) : 497 - 498
  • [44] The costs of triple-drug anti-HIV therapy for adults in the Americas
    Montaner, JSG
    Hogg, RS
    Weber, AE
    Anis, AH
    O'Shaughnessy, MV
    Schechter, MT
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (16): : 1263 - 1264
  • [45] PREVALENCE OF ANTI-HCV IN RECIPIENTS OF BLOOD FROM ANTI-HCV POSITIVE DONORS
    LARSEN, J
    SKAUG, K
    MAELAND, A
    HETLAND, G
    STORVOLD, G
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 32 (04) : 401 - 401
  • [46] PREVALENCE OF ANTI-HCV AND GENOTYPES IN FAMILY CONTACTS OF ANTI-HCV POSITIVE PATIENTS
    DIAGO, M
    ZAPATER, R
    TUSET, C
    CARBONELL, P
    GONZALEZ, C
    CORS, R
    VILLAR, F
    DASI, MA
    HEPATOLOGY, 1994, 20 (04) : A248 - A248
  • [47] The cyclophilin inhibitor DEBIO-025 has a potent dual anti-HIV and anti-HCV activity in treatment-naive HIV/HCV co-infected subjects
    Flisiak, Robert
    Horban, Andrzej
    Kierkus, Jarek
    Stanczak, Janusz
    Cielnak, Iwona
    Stanczak, Grzegorz P.
    Wiercinska-Drapalo, Alicja
    Siwak, Eva
    Higersberger, Jozef
    Aeschlimann, Christian
    Grosgurin, Pierre
    Nicolas, Valerie
    Dumont, Jean-Maurice
    Porchet, Herve
    Crabbe, Raf
    Scalfaro, Pietro
    HEPATOLOGY, 2006, 44 (04) : 609A - 609A
  • [48] SIGNIFICANCE OF SO-CALLED INDETERMINATE HCV RIBA IN ANTI-HIV NEGATIVE AND ANTI-HIV POSITIVE SUBJECTS
    MARTINOTPEIGNOUX, M
    MARCELLIN, P
    BRANGER, M
    ELIAS, A
    LEFORT, V
    ERLINGER, S
    BENHAMOU, JP
    GASTROENTEROLOGY, 1993, 104 (04) : A950 - A950
  • [49] DISTRIBUTION OF ABO AND RH BLOOD GROUPS AND SEROPREVALENCE OF HBSAG, ANTI-HCV, ANTI-HIV AND SYPHILIS IN HEALTHY DONORS: A SINGLE CENTER EXPERIENCE
    Ekinci, O.
    Kara, O.
    Dogan, A.
    Demircioglu, S.
    Demir, C.
    LEUKEMIA RESEARCH, 2017, 61 : S27 - S27
  • [50] Can HCV affect the efficacy of anti-HIV treatment?
    P. Filippini
    N. Coppola
    C. Scolastico
    G. Liorre
    R. Nocera
    E. Sagnelli
    F. Piccinino
    Archives of Virology, 2000, 145 : 937 - 944
12345